Modern Diagnostic IPO Set for 15% Premium Debut on BSE SME

Modern Diagnostic & Research Centre, a leading diagnostic chain, is making its market debut today, January 7, 2026, on the BSE SME platform. The company raised ₹36.9 crore through its IPO, which saw overwhelming investor interest with a 376.9x subscription.  

Grey market premium (GMP) trends indicate a ₹13–14 premium, projecting a listing price around ₹103–104 per share, translating to a 15% gain over the upper price band of ₹90.  

The IPO proceeds will be used to expand diagnostic centers, upgrade technology, and strengthen the balance sheet, positioning the company for growth in India’s booming healthcare sector.  

Key Highlights

• IPO Size: ₹36.9 crore via fresh issue of 4.1 million shares.  
• Subscription: Oversubscribed 376.9x; retail 342.5x, NII 702x, QIB 193.5x.  
• GMP Today: ₹13–14, indicating ~15% listing gain.  
• Listing Venue: BSE SME platform.  
• Company Profile: Operates diagnostic centers across India with strong financial turnaround.  
• Use of Funds: Expansion, tech upgrades, and balance sheet strengthening.  

Sources: Economic Times, Business Standard(3), News18, ET Now, IPO Watch